Edarbyclor Approved for Hypertension - MPR

Links shared publicly online about this topic.

  • 0
    total visits

Edarbyclor Approved for Hypertension - MPR

empr.com

Takeda announced that the FDA has approved Edarbyclor (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension in adults.

View full resource at empr.com

Tags: Heart, Heart Disease, High Blood Pressure, FDA, Cardiology

  • Share

Most Recently Shared on December 21, 2011 at 7:02 pm By:

Weight loss pill Qnexa wins panel vote and awaits approval

news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 11:08 pm By:

Diet_News News-Medical.Net Health News

Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq

3 weeks ago...

No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine - QualityPoint Technologies

qualitypointtech.net — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect. In an early benefit assessment pursuant to theView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 11:00 am By:

MedicalFeed MedicalFeed Health News Feed

No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine: The fixed drug combination of aliskiren and aml... http://t.co/3t61fV6F

1 month ago...

No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine

medicalnewstoday.com — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone hView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 7:05 am By:

mnt_hypertens MNT Hypertension Health News

No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine http://t.co/LloszBoY #hypertension

1 month ago...

Sihuan prepares anti-hypertension drug for clinical trial in China

health.yahoo.net — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinical trials in China by the end of 2013.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 6:40 am By:

HealthSociety Healthy Society Health News

Sihuan prepares anti-hypertension drug for clinical trial in China http://t.co/J4W7FnYX

2 months ago...

Sihuan prepares anti-hypertension drug for clinical trial in China

health.yahoo.net — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinical trials in China by the end of 2013.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 5:50 am By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Sihuan prepares anti-hypertension drug for clinical trial in China: HONG KONG (Reuters) - Chinese drugmaker Sihu... http://t.co/dpqo6TsY

2 months ago...

Sihuan prepares anti-hypertension drug for clinical trial in China | Reuters

reuters.com — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinicalView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 5:00 am By:

HealthNews2 Health News Health News

Sihuan prepares anti-hypertension drug for clinical trial in China: HONG KONG (Reuters) - Chinese ... http://t.co/uslJ66bp #health #news

2 months ago...

Sihuan prepares anti-hypertension drug for clinical trial in China | Reuters

reuters.com — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinicalView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 4:47 am By:

HealthPassion HealthPassion Health News

Sihuan prepares anti-hypertension drug for clinical trial in China: HONG KONG (Reuters) - Chinese drugmaker Sihu... http://t.co/13Uq1i2C

2 months ago...

Sihuan prepares anti-hypertension drug for clinical trial in China | Reuters

reuters.com — “HONG KONG (Reuters) - Chinese drugmaker Sihuan Pharmaceutical Holdings Group Ltd has registered its anti-hypertensive drug with the country's drug regulator and hopes to obtain approval to begin clinicalView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 12, 2012 at 4:45 am By:

Reuters_Health Reuters Health Health News

Sihuan prepares anti-hypertension drug for clinical trial in China http://t.co/t6QG9gQO

2 months ago...

FDA approves drug combo to treat hypertension

nephrologynews.com — “The drug is a fixed-dose therapy that combimes an angiotensin II receptor blocker (ARB) with the diuretic chlorthalidone in a once-daily, single tablet.View full resource at nephrologynews.com

  • View Related
  • Share

Most Recently Shared on December 28, 2011 at 4:22 pm By:

Children With PAH May Benefit From Sildenafil

medicalnewstoday.com — “Sildenafil is currently approved for adult pulmonary arterial hypertension (PAH); however, new research presented at CHEST 2011, the 77th annual meeting of the American College of Chest PhysiciansView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 25, 2011 at 10:05 am By:

TWYNSTA™ For Controlling Hypertension Approved By Health Canada

medicalnewstoday.com — “Health Canada has approved TWYNSTA™ (telmisartan and amlodipine) for the treatment of mild to moderate essential hypertension (when the cause of high blood pressure is unknown) in individualView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 7, 2011 at 12:05 pm By:

mnt_drugapprov MNT Drug Approvals Health News

TWYNSTA™ For Controlling Hypertension Approved By Health Canada http://mnt.to/429j #regulatory

7 months ago...

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension

news-medical.net — “CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 1:17 pm By:

NewsMedical News-Medical.Net Health News

CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension: CVRx, Inc., a private ... http://t.co/mER5QQs

8 months ago...

Implantable Device May Ease Tough-to-Treat Hypertension - MSN Health - Heart & Cardiovascular

health.msn.com — “But complication rate was relatively high and FDA approval may be years away researchers sayView full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 9:29 pm By:

FDA OKs study design on Medtronic product that firm is bullish on

medcitynews.com — “FDA approves study design of Medtronic's hypertension product. Read how the maker of new innovative medical devices can enroll patients for a trial.View full resource at medcitynews.com

  • View Related
  • Share

Most Recently Shared on July 12, 2011 at 7:29 pm By:

medcitynews MedCity News Health News

FDA OKs study design on Medtronic product that firm is bullish on http://bit.ly/qeuHD5

10 months ago...

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

news-medical.net — “Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 12, 2011 at 6:46 am By:

Stroke_News News-Medical.Net Health News

Stroke News: FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension: Medtronic, ... http://twurl.nl/wwvm6n

10 months ago...

Advertisement